Generic Name and Formulations:
Hyoscyamine sulfate 0.125mg; chewable melt tabs; peppermint flavor.
Company:
Meda Pharmaceuticals
As a drying agent in the relief of symptoms of acute rhinitis.
<2yrs: not recommended. 2–12yrs: ½–1 tab every 4 hrs or as needed; max 6 tabs/day. ≥12yrs: 1–2 tabs every 4 hrs or as needed; max 12 tabs/day. Tabs may be chewed or dissolved on tongue and swallowed.
Anticholinergic.
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis.
High environmental temperature. Fever. Diarrhea: exclude partial GI obstruction. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hypertension. CHF. Arrhythmias. Tachycardia. Renal disease. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Additive effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclic antidepressants, antihistamines. Antacids may inhibit absorption.
Anticholinergic effects (e.g., drowsiness, dizziness, blurred vision, urinary hesitancy, palpitations, mydriasis, dry mouth), nausea, taste loss, impotence, rash, confusion, psychosis.
Tabs—100
Adjunct in irritable bowel syndrome, peptic ulcer, spastic or functional GI disorders, neurogenic bowel disorders, colic.
<2yrs: not recommended. 2–12yrs: ½–1 tab every 4 hrs or as needed; max 6 tabs/day. ≥12yrs: 1–2 tabs every 4 hrs or as needed; max 12 tabs/day. Tabs may be chewed or dissolved on tongue and swallowed.
Anticholinergic.
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis.
High environmental temperature. Fever. Diarrhea: exclude partial GI obstruction. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hypertension. CHF. Arrhythmias. Tachycardia. Renal disease. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Additive effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclic antidepressants, antihistamines. Antacids may inhibit absorption.
Anticholinergic effects (e.g., drowsiness, dizziness, blurred vision, urinary hesitancy, palpitations, mydriasis, dry mouth), nausea, taste loss, impotence, rash, confusion, psychosis.
Tabs—100
Parkinsonism: to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis.
<2yrs: not recommended. 2–12yrs: ½–1 tab every 4 hrs or as needed; max 6 tabs/day. ≥12yrs: 1–2 tabs every 4 hrs or as needed; max 12 tabs/day. Tabs may be chewed or dissolved on tongue and swallowed.
Anticholinergic.
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis.
High environmental temperature. Fever. Diarrhea: exclude partial GI obstruction. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hypertension. CHF. Arrhythmias. Tachycardia. Renal disease. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Additive effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclic antidepressants, antihistamines. Antacids may inhibit absorption.
Anticholinergic effects (e.g., drowsiness, dizziness, blurred vision, urinary hesitancy, palpitations, mydriasis, dry mouth), nausea, taste loss, impotence, rash, confusion, psychosis.
Tabs—100
Anticholinesterase poisoning.
<2yrs: not recommended. 2–12yrs: ½–1 tab every 4 hrs or as needed; max 6 tabs/day. ≥12yrs: 1–2 tabs every 4 hrs or as needed; max 12 tabs/day. Tabs may be chewed or dissolved on tongue and swallowed.
Anticholinergic.
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis.
High environmental temperature. Fever. Diarrhea: exclude partial GI obstruction. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hypertension. CHF. Arrhythmias. Tachycardia. Renal disease. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Additive effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclic antidepressants, antihistamines. Antacids may inhibit absorption.
Anticholinergic effects (e.g., drowsiness, dizziness, blurred vision, urinary hesitancy, palpitations, mydriasis, dry mouth), nausea, taste loss, impotence, rash, confusion, psychosis.
Tabs—100
Lower urinary tract spasm.
<2yrs: not recommended. 2–12yrs: ½–1 tab every 4 hrs or as needed; max 6 tabs/day. ≥12yrs: 1–2 tabs every 4 hrs or as needed; max 12 tabs/day. Tabs may be chewed or dissolved on tongue and swallowed.
Anticholinergic.
Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Unstable cardiovascular status in acute hemorrhage. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis.
High environmental temperature. Fever. Diarrhea: exclude partial GI obstruction. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hypertension. CHF. Arrhythmias. Tachycardia. Renal disease. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Additive effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclic antidepressants, antihistamines. Antacids may inhibit absorption.
Anticholinergic effects (e.g., drowsiness, dizziness, blurred vision, urinary hesitancy, palpitations, mydriasis, dry mouth), nausea, taste loss, impotence, rash, confusion, psychosis.
Tabs—100